Anlon Healthcare Stock Hits 5% Upper Circuit and Fresh 52-Week High, Up 24.57% In One Month

Rajkot, November 18: Anlon Healthcare’s share price is witnessing strong investor demand today, hitting the 5% upper circuit and reaching a fresh 52-week high, driven by strong investor demand following the company’s robust financial performance for Q2 FY26 and the first half of 2025. As of 1:45 PM, the stock was trading at ₹157.61, up 7.50 points. During the session, shares moved within a range of ₹151.61 to ₹157.61, with a traded volume of 2.64 lakh shares. The company’s market capitalization stood at ₹798 crore.

Anlon Healthcare Limited (BSE: 544497, NSE: AHCL) is a research-driven chemical manufacturing company specialising in the production of high-purity pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs). These products serve as essential building blocks for finished dosage formulations (like tablets, capsules, and syrups), as well as ingredients for nutraceuticals, personal care, and animal health products. The company was established in 2013 and is headquartered in Rajkot, Gujarat.

Shares Rise After Recent Financial Performance

For Q2 FY26, the company’s total income rose to ₹52.23 crore from ₹24.21 crore in Q2 FY25, marking a rise of 115.71% YoY. EBITDA increased from ₹7.57 crore to ₹13.77 crore, a rise of 81.88%. Profit after tax increased from ₹2.59 crore last year to ₹9.32 crore this quarter, a rise of 259.42%. The PAT margin also surged from 10.71% to 17.84%, up by 713 basis points.

For H1 FY26, total income stood at ₹85.53 crore compared to ₹62.11 crore in H1 FY25, a rise of 37.72%. EBITDA increased to ₹20.01 crore from ₹14.55 crore, up 37.52% YoY. PAT for the half year was at ₹12.86 crore versus ₹6.36 crore a year earlier, rising 102.53%. The PAT margin improved from 10.23% to 15.04%, a gain of 481 basis points.

Investor Takeaway

Anlon Healthcare’s share price has been climbing steadily, gaining 24.57% over the past month, 13.37% in the last two weeks, and 8.01% in the past week. The rally is supported by the company’s strong financial performance, with total income rising 115.71% and PAT surging 259.42% in the recent period. In the first half of 2025, total income grew 37.72%, while PAT jumped 102.53%. These better-than-expected results have been the primary driver of the stock’s short-term momentum.

REF: https://nsearchives.nseindia.com/corporate/ANLON2013_12112025120727_AHLPressRelease12112025Signed.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations